Gastroesophageal reflux disease incidence among male patients with irritable bowel syndrome: A single-center cross-sectional study in southern Iran
- PMID: 36852149
- PMCID: PMC9958336
- DOI: 10.1002/jgh3.12867
Gastroesophageal reflux disease incidence among male patients with irritable bowel syndrome: A single-center cross-sectional study in southern Iran
Abstract
Background and aim: Gastrointestinal reflux disease (GERD) and irritable bowel syndrome (IBS) are among the most common gastrointestinal disorders in which the overlap of these diseases and their syndromes has been frequently reported. In this study, we aimed to evaluate GERD incidence among IBS patients and the related risk factors.
Methods: Male patients aged 18-60 years with an impression of IBS and referred to the gastrointestinal clinic from March 2019 to 2020 in Shiraz, Iran, were included in this study.
Results: Among the 163 enrolled patients with an average age of 31.53 ± 9.38 years, 64 (39.3%) were diagnosed with GERD. Based on statistical analysis, there was a significant association between GERD and the IBS patients' age (P = 0.006), smoking (P = 0.011), and alcohol consumption (P = 0.043). Also, GERD among IBS patients was significantly associated with the type of IBS (P < 0.001), with IBS-D having the lowest incidence (19.4%) and IBS-M the highest incidence of GERD (66.7%). Based on multivariate analysis, smoking had a reverse and significant correlation with lower incidence of GERD (OR = -1.364; P = 0.002).
Conclusion: Our results demonstrate that among male IBS patients, younger age, smoking, and alcohol consumption were among the risk factors for GERD. These findings may provide further insight into the best approach to treating these diseases.
Keywords: Iran; gastrointestinal reflux disease; irritable bowel syndrome; male.
© 2023 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Similar articles
-
Cigarette smoking and its association with overlapping gastroesophageal reflux disease, functional dyspepsia, or irritable bowel syndrome.Intern Med. 2011;50(21):2443-7. doi: 10.2169/internalmedicine.50.6012. Epub 2011 Nov 1. Intern Med. 2011. PMID: 22041340
-
Epidemiology and risk factors of uninvestigated dyspepsia, irritable bowel syndrome, and gastroesophageal reflux disease among students of Damascus University, Syria.J Epidemiol Glob Health. 2016 Dec;6(4):285-293. doi: 10.1016/j.jegh.2016.07.001. Epub 2016 Aug 5. J Epidemiol Glob Health. 2016. PMID: 27501053 Free PMC article.
-
Impact of concomitant dyspepsia and irritable bowel syndrome on symptom burden in patients with gastroesophageal reflux disease.J Formos Med Assoc. 2019 Apr;118(4):797-806. doi: 10.1016/j.jfma.2018.12.002. Epub 2018 Dec 21. J Formos Med Assoc. 2019. PMID: 30584006
-
Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS)--is it one disease or an overlap of two disorders?Dig Dis Sci. 2009 Sep;54(9):1829-34. doi: 10.1007/s10620-008-0594-2. Epub 2008 Dec 10. Dig Dis Sci. 2009. PMID: 19082721 Review.
-
Gastroesophageal reflux disease and irritable bowel syndrome: a common overlap syndrome.Curr Gastroenterol Rep. 2006 Aug;8(4):261-5. doi: 10.1007/s11894-006-0045-1. Curr Gastroenterol Rep. 2006. PMID: 16886306 Review.
Cited by
-
Causal association of gastroesophageal reflux disease on irritable bowel syndrome: a two-sample Mendelian randomization study.Front Genet. 2024 Mar 27;15:1328327. doi: 10.3389/fgene.2024.1328327. eCollection 2024. Front Genet. 2024. PMID: 38601073 Free PMC article.
-
Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications.Microorganisms. 2023 Sep 22;11(10):2369. doi: 10.3390/microorganisms11102369. Microorganisms. 2023. PMID: 37894027 Free PMC article. Review.
-
Overlap Between Gastroesophageal Reflux Disease and Irritable Bowel Syndrome and Its Impact on Quality of Life.Cureus. 2023 Dec 20;15(12):e50840. doi: 10.7759/cureus.50840. eCollection 2023 Dec. Cureus. 2023. PMID: 38249262 Free PMC article.
References
-
- Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta‐analysis. Lancet Gastroenterol. Hepatol. 2020; 5: 908–17. - PubMed
-
- Fairbrass KM, Costantino SJ, Gracie DJ, Ford AC. Prevalence of irritable bowel syndrome‐type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta‐analysis. Lancet Gastroenterol. Hepatol. 2020; 5: 1053–62. - PubMed
-
- Herregods TV, Bredenoord AJ, Smout AJ. Pathophysiology of gastroesophageal reflux disease: new understanding in a new era. Neurogastroenterol. Motil. 2015; 27: 1202–13. - PubMed
LinkOut - more resources
Full Text Sources